{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Ultra-Long-Acting Insulins: A Review of Efficacy,Safety, and Implications for Practice
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on the clinical properties, dosing, packaging and place in therapy of ultralong acting insulins.Learning Objectives
After completing this continuing education activity you will be able to:
- Describe the pharmacodynamics of insulin glargine U100, U300, and insulin degludec.
- Describe the benefits of long acting insulins in clinical practice.
- Determine proper dosing of long acting insulins in clinical practice.
Disclosures
The authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Price:
$17.95
Credits:
- ACPE 1.5 CH
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Pharmacist
Test Code: JAANP0718Pharm
Published: February 2019
Expires: 9/12/2025
Sources:
Allied Health Collection
Required Passing Score: 13/18 (72%)
Categories:
Endocrinology
Specialties:
Pharmacy,
Pharmocotherapy
Topics:
Diabetes